Nyxoah (NYXH) Other Non-Current Assets (2024 - 2025)
Nyxoah's (NYXH) quarterly Other Non-Current Assets came in at $105928.0 in Q4 2025, down 11.49% year-on-year from $119682.7 in Q4 2024, and up 68027.74% quarter-over-quarter from $155.48 in Q3 2025.
Nyxoah (NYXH) Other Non-Current Assets (2024 - 2025) Analysis & Trends
Nyxoah's Other Non-Current Assets history runs 2 years deep, the most recent figure standing at $105928.0 for Q4 2025.
- On a quarterly basis, Other Non-Current Assets fell 11.49% year-over-year to $105928.0 in Q4 2025; TTM through Dec 2025 was $105928.0, a 11.49% decrease from a year earlier, with the FY2025 full-year figure at $105928.0, down 11.49% from the prior year.
- Other Non-Current Assets climbed to $105928.0 in Q4 2025 per NYXH's latest filing, from $155.48 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $119682.7 in Q4 2024 and bottomed at $155.48 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Nyxoah | 56.02 Mn | 103.00 Mn | 4.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 105,927.96 |
| Sep 30, 2025 | 155.48 |
| Dec 31, 2024 | 119,682.68 |